Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients;Influenza di terapie antiretrovirali sullo spessore medio-intimale carotideo in pazienti HIV-positivi

Giornale Italiano di Cardiologia

Volumn 10, Issue 9, 2009, Pages 596-601

  Ferraro, Sergio ^a   Paolillo, Stefania ^b   Gargiulo, Miriam ^a   Costanzo, Pierluigi ^b   Maggi, Paolo ^c   Chirianni, Antonio ^a   Chiariello, Massimo ^b   Filardi, Pasquale Perrone ^b  

^a Azienda Ospedaliera di Rilievo Nazionale D Cotugno   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Atherosclerosis; Carotid artery disease; HIV; Protease inhibitors

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; AORTA; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE;

ADULT; AGED; CAROTID ARTERIES; FEMALE; HIV PROTEASE INHIBITORS; HIV REVERSE TRANSCRIPTASE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 70350118312     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860 (Pubitemid 28135961)
2. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348: 702-710
3. Friis-Møller N, Weber R, Reiss P, et al, for the DAD study group. Cardiovascular disease risk factor in HIV-patients, association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-1193
4. Friis-Møller N, Sabin CA, Weber R, et al, for the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
5. Friis-Møller N, Reiss P, Sabin CA, et al, for the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356: 1723-1735
6. Hürliman D, Weber R, Enseleit F, Lüscher TF. HIV-infection, antiretroviral therapy, and endothelium. Herz 2005; 30: 472-480
7. Behrens GM. Metabolic syndrome and hyperlipidemia in HIV- positive patients. Herz 2005; 30: 458-466 (Pubitemid 41367136)
8. Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001; 104: 257-262
9. Meng Q, Lima JA, Lai H, et al. Coronary artery calcification, atherogenic changes and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J 2002; 144: 642-648
10. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262-269 (Pubitemid 28090756)
11. Bots ML, Grobbee DE, Hofman A, Witteman JC. Common carotid intima-media thickness and risk of acute myocardial infarction: the role of lumen diameter. Stroke 2005; 36: 762-767 (Pubitemid 40490621)
12. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
13. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494
14. Aminbakhsh A, Mancini GB. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 1999; 22: 149-157 (Pubitemid 29516419)
15. Ricotta JJ, Bryan FA, Bond MG, et al. Multicenter validation study of real time (B-mode) ultrasound, arteriography, and pathologic examination. J Vasc Surg 1987; 6: 512-520
16. Steinbach JC, Saboya MI, Le Bourg F, Petit H, Gény B, Stephan D. A new approach to arterial rigidity: ultrasonic tissue mode imaging. Arch Mal Coeur Vaiss 2003; 96: 725-728 (Pubitemid 36966323)
17. Ranke C, Trappe HJ. Blood flow velocity measurements for carotid stenosis estimation: interobserver variation and interequipment variability. Vasa 1997; 26: 210-214 (Pubitemid 27334046)
18. McLeod AL, Uren NG, Wilkinson IB, et al. Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans. J Hypertens 2004; 22: 363-368
19. Hazenberg MD, Stuart JW, Otto SA, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000; 95: 249-255
20. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204. (Pubitemid 30459555)
21. Barbara G, Fisher SD, Lipshultz SE. Pathogenesis oh HIV-associated cardiovascular complications. Lancet Infect Dis 2001; 1: 115-124
22. Maggi P, Serio G, Epifani G, et al. Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors. AIDS 2000; 14: F123-F128. (Pubitemid 30840030)
23. Maggi P, Perilli F, Lillo A, et al. Rapid progression of carotid lesions in HAART-treated HIV-1 patients. Atherosclerosis 2007; 192: 407-412 (Pubitemid 46726322)
24. Seminari E, Pan A, Voltini G, et al. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis 2002; 162: 433-438 (Pubitemid 34457950)
25. Sankatsing RR, Wit FW, Vogel M, et al. Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors. Atherosclerosis 2009; 202: 589-595
26. Chironi G, Escaut L, Gariepy J, et al. Carotid intima-media thickness in heavily pretreated HIV-infected patients. J Acquir Immune Defic Syndr 2003; 32: 490-493 (Pubitemid 36423119)
27. Currier JS, Kendall MA, Zackin R, et al, for the AACTG 5078 Study Team. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 2005; 10: 927-933
28. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109: 1603-1608 (Pubitemid 38451715)